DemonsTTRateNCT07358078
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial sites expanded: 24 → 27 locations
- Eligibility criteria expanded, about 3 words
- Minor Trial sites expanded: 4 → 24 locationsv4
- Minor Study sites: 3 to 4v3
- Minor Study sites: 1 to 3v2
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
New York Heart Association (NYHA) Class
Timeframe: From time of ATTR-CM diagnosis up to 5 years
Outpatient Diuretic Intensification
Timeframe: From time of enrollment for up to 5 years
Norfolk Quality of Life - Diabetic Neuropathy (QOL-DN) Total Score
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Kansas City Cardiomyopathy Questionnaire (KCCQ)
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Patient Global Impressions - Change (PGI-C)
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Patient Global Impressions - Severity (PGI-S);
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Treatment Satisfaction Questionnaire for Medication version 9 (TSQM-9)
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Arms and interventions
Patients with ATTR-CM
Patients with ATTR-CM.
Sites
27 sites in 3 countries
United States 13, Japan 10, Germany 4